Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
NCT ID: NCT02427087
Last Updated: 2015-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2013-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of our research is that aerobic activity had a favorable impact on NAFLD. It is expected that the intervention of physical activity causes a decrease or no weight, decreased levels of aminotransferases, decreased insulin resistance assessed by homeostasis model assessment (HOMA) index and consequently decrease or reversal of hepatic steatosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)
NCT01418027
Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly
NCT00779207
Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD
NCT06186869
Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD
NCT06124456
Changes in Intrahepatic Lipids With Exercise
NCT02181270
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Laboratorial Assays (baseline and end of the protocol)
* AST, ALT, FA, GGT, albumine, Fe, fasting glucose, insulin, Total cholesterol, HDL, LDL, Triglycerides;
* TNFalfa, IL6, and adiponectin.
Anthropometrical Evaluation (baseline and end of the protocol)
* BMI, waist circumference, percent body fat, body fat mass, lean body mass
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Aerobic training
Aerobic training continuous (n=19 patients) carry a protocol continuous aerobic training twice a week for 24 weeks and the session will last 60 minutes/2 days/week with recommendation for healthy diet.
Continuous Aerobic Training twice
Supervised aerobic exercise program of 60 min/2 days/week at 60-85% of heart rate reserve for 24 weeks and healthy diet
Healthy Diet
Diet group (21) Recommendation for healthy diet.
Healthy diet
Diet group (n=21 patients) only recommendation for healthy diet.
Healthy Diet
Diet group (21) Recommendation for healthy diet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Aerobic Training twice
Supervised aerobic exercise program of 60 min/2 days/week at 60-85% of heart rate reserve for 24 weeks and healthy diet
Healthy Diet
Diet group (21) Recommendation for healthy diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Biopsy-liver until 24 months previous that prove NAFLD or NASH
* Patients who agree to participate in the study and all signed informed consent.
Exclusion Criteria
* Without medical clearance for physical activity
* Without availability to attend appointments and physical activities 2x/week
* Significant change in dietary habits and/or exercise in the last 3 months that resulted in weight loss \> 5%.
35 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Pinto Marques Oliveira
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CLAUDIA PM MD OLIVEIRA, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo, School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Sao Paulo School of Medicine
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.